Eastwood Bio-Medical Canada Inc. (TSXV:EBM)
Canada flag Canada · Delayed Price · Currency is CAD
0.6500
-0.0400 (-5.80%)
Apr 22, 2026, 12:05 PM EST

TSXV:EBM Statistics

Total Valuation

TSXV:EBM has a market cap or net worth of CAD 47.53 million. The enterprise value is 47.59 million.

Market Cap47.53M
Enterprise Value 47.59M

Important Dates

The next estimated earnings date is Friday, June 26, 2026.

Earnings Date Jun 26, 2026
Ex-Dividend Date n/a

Share Statistics

TSXV:EBM has 68.89 million shares outstanding.

Current Share Class 68.89M
Shares Outstanding 68.89M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.21%
Owned by Institutions (%) n/a
Float 20.95M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 66.05
PB Ratio -28.80
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio 3,323.64
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -152.39
EV / Sales 66.14
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.04

Current Ratio 0.04
Quick Ratio 0.04
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -29.74

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -73.47%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 16.20%
Weighted Average Cost of Capital (WACC) 5.06%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 3.16
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +53.33% in the last 52 weeks. The beta is 0.15, so TSXV:EBM's price volatility has been lower than the market average.

Beta (5Y) 0.15
52-Week Price Change +53.33%
50-Day Moving Average 0.72
200-Day Moving Average 0.63
Relative Strength Index (RSI) 48.21
Average Volume (20 Days) 6,217

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, TSXV:EBM had revenue of CAD 719,584 and -312,305 in losses. Loss per share was -0.00.

Revenue719,584
Gross Profit 496,102
Operating Income -267,365
Pretax Income -312,305
Net Income -312,305
EBITDA -256,911
EBIT -267,365
Loss Per Share -0.00
Full Income Statement

Balance Sheet

The company has 13,462 in cash and 74,667 in debt, with a net cash position of -61,205 or -0.00 per share.

Cash & Cash Equivalents 13,462
Total Debt 74,667
Net Cash -61,205
Net Cash Per Share -0.00
Equity (Book Value) -1.65M
Book Value Per Share -0.02
Working Capital -1.83M
Full Balance Sheet

Cash Flow

Operating Cash Flow 14,301
Capital Expenditures n/a
Depreciation & Amortization 10,454
Net Borrowing -8,075
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 68.94%, with operating and profit margins of -37.16% and -43.40%.

Gross Margin 68.94%
Operating Margin -37.16%
Pretax Margin -43.40%
Profit Margin -43.40%
EBITDA Margin -35.70%
EBIT Margin -37.16%
FCF Margin n/a

Dividends & Yields

TSXV:EBM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -0.66%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

TSXV:EBM has an Altman Z-Score of -32.32 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -32.32
Piotroski F-Score 5